Opening of Gentian's new facility at our HQ in Norway

24. Aug 2022 | 2 min read

Opening of Gentian's new facility at our HQ in Norway

Today 24th August the Minister of Health and Care Services of Norway Ingvild Kjerkol visited Gentian's HQ where she inaugurated our new facility.

Gentian's process to bring diagnostic tests to healthcare professionals

Before the official opening of the facility the minister was invited on a tour around the redecorated and extended facilities with new offices areas, instrument hall, R&D lab and manufacturing zones. The new facility is a result of Gentian’s growth and the need to better cater for research and development and manufacturing of new diagnostic tests for the future.

On the tour she met Gentian employees showing our process from idea to shipped products. She met employees from R&D, Regulatory Affairs and Quality Assurance, Manufacturing, Logistic, Marketing and Sales.

 

hilja-and-hm

Minister of Health and Care services Ingvild Kjerkol (right) and Gentian Diagnostics' CEO Dr. Hijla Ibert

 

meeting-the-employee

Minister of Health and Care services Ingvild Kjerkol and Hanne Tollerud, Mayor in Moss, together with Gentian Diagnostics' CEO Dr. Hilja Ibert and Tom Nilsen, Head of Product Development

The link to press release here (In Norwegian)

You may also read


Webinar: Beyond creatinine: Why it’s time to integrate cystatin C into clinical practice

Mar 05, 2026

Webinar: Beyond creatinine: Why it’s time to integrate cystatin C into clinical practice

Time to integrate cystatin C into clinical practice Webinar | March 25th, 2026 | 09:00 AM PT / 12:00 PM ET /..

See you at

Feb 24, 2026

See you at "Lederdagene 2026" - Nordic event

Meet Gentian at "Lederdagene 2026" Gentian Diagnostics look forward to attend NITO Lederdagene 4th-5th March...

Canine CRP customer story - First-line test to detect inflammation

Jan 29, 2026

Canine CRP customer story - First-line test to detect inflammation

Gentian Canine CRP continuously available since 2013 The Gentian Canine CRP immunoassay, available since..